Search Tag: prognosis
2025 03 Nov
Accurate preoperative staging remains central to treatment planning and prognosis in uterine cervical cancer (CC). Cross-sectional imaging has become part of the staging pathway, yet cystoscopy is still used to confirm mucosal infiltration for stage IVA classification. New multicentre evidence highlights that what is seen on magnetic resonance...Read more
2025 03 Nov
Accurate preoperative staging remains central to treatment planning and prognosis in uterine cervical cancer (CC). Cross-sectional imaging has become part of the staging pathway, yet cystoscopy is still used to confirm mucosal infiltration for stage IVA classification. New multicentre evidence highlights that what is seen on magnetic resonance...Read more
2025 02 Sep
Microvascular invasion is a key histopathological feature linked to recurrence and poor survival in hepatocellular carcinoma, yet it is confirmed only after surgery, limiting its value for preoperative decision-making. A retrospective multicentre analysis of 655 surgically confirmed cases explored whether three-dimensional fractal dimension derived...Read more
2025 02 Sep
Microvascular invasion is a key histopathological feature linked to recurrence and poor survival in hepatocellular carcinoma, yet it is confirmed only after surgery, limiting its value for preoperative decision-making. A retrospective multicentre analysis of 655 surgically confirmed cases explored whether three-dimensional fractal dimension derived...Read more
2025 12 Jul
Achieving clear resection margins is critical in the surgical management of locally recurrent rectal cancer (LRRC), as it is closely linked to improved overall and disease-free survival. However, the feasibility of complete resection varies widely depending on tumour location and biological behaviour. A recent retrospective study published in...Read more
2025 09 Jun
Systemic sclerosis–associated interstitial lung disease (SSc-ILD) is a life-threatening complication of systemic sclerosis, characterised by variable progression and challenging prognosis. While pulmonary function tests (PFTs) and high-resolution CT (HRCT) are the standard tools for monitoring disease, they often fall short in predicting outcomes,...Read more
2024 16 Nov
Diffuse large B-cell lymphoma (DLBCL) is a common and aggressive non-Hodgkin lymphoma, accounting for approximately 30% of cases in Western countries. DLBCL patients experience varied outcomes depending on disease stage, tumour burden and individual health profiles. For years, the International Prognostic Index (IPI) has served as a critical tool...Read more
2024 03 Nov
Lung cancer remains one of the most prevalent forms of cancer globally and is the leading cause of cancer-related mortality. Despite advancements in medical research, the overall survival (OS) rate for lung cancer patients continues to be low, underlining the urgent need for more accurate diagnostic and prognostic tools. When used separately,...Read more
2024 13 Mar
Breast cancer (BC) is a prevalent disease, affecting millions of women globally each year, with significant mortality rates. It is a complex illness with various subtypes, presentations, and responses to treatment. While advancements in therapy have improved outcomes for certain types of BC, recurrence remains a concern for a portion of patients....Read more